Investigation of unique immune microenvironment of Primary CNS Lymphoma (2017-2020)
Abstract
This study will investigate how the immune system responds to the development of brain lymphoma. It is expected that this lymphoma develops due to a defective immune response. It is unknown why the tumour is so effective at evading the immune response but if the hypothesis is correct, then the application of new drugs that stimulate the immune system to attack the lymphoma could lead to a marked improvement in survival without the need for toxic chemotherapy and radiation.